Only four of the cases (8 per cent.) were in women, and of these one was probably primary pleural, one a haemangio-endothelioma, one of the multiple bronchial type, and only one of the common type of bronchial carcinoma. In no one case was the disease found in a patient of the Jewish race. As the City of London Chest Hospital is in the centre of a district in which the Jewish population is large this is somewhat striking.
The age incidence is as follows: At the Centenary Meeting of the B.M.A. last year some laryngologists expressed the opinion that bronchoscopy should be in the hands of the laryngologists. To us it appears that the bronchi are so obviously the field of the chest physician that though every chest physiciani should not be a bronchoscopist, the bronchoscopist may most advisedly be a chest physician.
WVe wish to acknowvledge with gratitude the help of Dr.
Roodhouse Gloyne and I)r. It will be remembered that Barber and Oriel make the following statements:
1. That a proteose may be extracted from the urine by ether, and precipitated from the ether extract by alcohol.
2. That although proteose is present in small quantities in health, it is very much increased in cases of allergy.
3. In cases of. urticaria and asthma the proteose is found in large quantities in urine passed during the attack, while it is small in amount or absent between the attacks.
4. Solutions of the proteose obtained in cases of allergy, when injected intradermally, produce specific skin reactions in the patient from whom the proteose was obtained; sornetimes they produce reactions in those suffering from the same condition, but not in normal persons.
5. This sensitivity may be transferred by the PrausnitzKustner method.
6. In cases of epidermal sensitization, positive reactions may be obtained by application of the proteose to the surface of the skin by means of a patch test.
7. Comparatively large doses of proteose injected intradermally cause an exacerbation of the symptoms, while minute doses over a long period lead to a cure of the condition.
Freeman has been unable to confirm these results, while Lyon, Percival, and Stewart found that twenty-one out of twenty-five proteoses which they prepared gave positive reactions not only in the patients from whom they were prepared, but also in normal persons and in those suffering from various skin diseases. They also found that proteose prepared from a patient suffering from the eczema-asthma svndrome gave a negative reaction in the patient from whom it was prepared, but positive reactions in other persons. A case of angioneurotic oedema failed to respond to its own proteose, but gave a positive reaction to a proteose prepared from a case of chronic urticaria. Two cases of asthma in which the proteose content of the urine was very high gave negative reactions to their own proteoses. They conclude that the peculiarity of proteose lies not in its Specificity, but in its property of producing a local inflammation of great intensity in a proportion of individuals.
Eichenlaub treated eighteen patients suffering from skin diseases with proteose. All of the patients who gave definitely positive skin reactions-that is, ten of the eighteen patients-appeared to receive some benefit from the treatment. Only one of the other eight persons improved. Cases in which complete failure was observed gave no local or general reactions to their proteoses, but a case of psoriasis derived benefit from the treatment, although a positive skin reaction was not obtained. In thirty-five estimations made in thirty-three normal persons the average amount of proteose excreted was 0.12 c.cm. Of the twenty-five cases in which skin tests were made 16 per cent. only were positive to protcoZe. .Z1 the seventy estimations made in sixty-eight untreated skin cases the average amount excreted-0.15-was slightly higher than in the normal controls, while 67 per cent. of patients were positive to their own proteoses. The majority of the cases were controlled by injections of 1 in 1,000 peptone solution. Of eighteen normal persons four gave positive reactions to proteose and peptone, three were positive to peptone only, and none were positive to proteose only. Of fifty untreated skin cases none were positive to peptone only, nine were positive to proteose only, and twenty-two gave positive reactions to both. Six cases were tested after treatment and cure: one of these remained positive to peptone, but none were positive to proteose.
A case of angioneurotic oedema excreted more proteose during an attack than in a quiescent interval, and only that passed during the attack gave a positive skin reaction. This agrees with the work of Barber and Oriel. It was found, however, that the skin reaction obtained does not always correspond with the amount of proteose excreted. In the cases of untreated psoriasis the majority of the acute cases gave positive reactions, while the majority of the subacute and chronic cases gave negative reactions. More proteose was excreted in cases of acute than in cases of subacute or chronic psoriasis. There was a reduction in the average amount of proteose excreted prior to and after treatment in cases of psoriasis, but in cases of eczema this reduction,.was very slight. Of the latter cases, before treatment, 66 per cent. gave positive skin reactions to their own proteoses, while after treatment and relief none of the cases gave positive reactions. The highest average excretion of proteose was obtained in cases of Besnier's prurigo, but the highness of this figure was due to one case in which the excretion was 0.75. The other cases fell within normal limits. In a case of chronic urticaria, treated and cured by proteose, the excretion of proteose diminished and the skin reactions to proteose and peptone became negative. In the cases of psoriasis which were relieved as a result of treatment by this method, the skin reaction to proteose prior to treatment was positive in all cases, while reactions after treatment were negative. [ THE BRITISH the optimum dose must be minute. I originally used a 1 in 1,000 solution for testing purposes, but I now use a I in 100,000, or even 1 in 1,000,000, for the preliminary test. Cases treated recently have given better results than the earlier ones, and I attribute this to the reduction of the therapeutic dose. The results of skin tests in normal persons and patients suffering from the skin diseases under discussion show very striking differences, for while only 16 per cent. of normal persons gave positive reactions to their own proteoses, 67 per cent. of the skin cases responded in this way. With regard to the statements of Barber aiid Oriel, my results tend to show that the amount of proteose excreted is not of very great significance, for the difference between that excreted in health and in various skin diseases was not great. Mfore, however, was excreted from patients suffering from skin diseases, and in one case of angioneurotic oedema more was excreted during an attack than in a quiescent interval. I have also confirmed the statement that exacerbations of the skin condition may follow r,clatively large doses of proteose. My clinical findings agree very closely with those of Eichenlaub, and I agree with his conclusion that the method should be more widely used in order that its full value may be determined. SUMMARY 1. Treatment with proteose prepared from the patient's uirine has given satisfactory results in cases of chronic eczema and urticaria. Less striking results were obtained in cases of psoriasis and Besnier's prurigo, but benefit seemed to be derived from the treatment in some cases.
2. Sixteen per cent. of normal persons and 67 per cent. of patients suffering from various skin diseases gave positive reactions to their own proteoses. Slightly more proteose was excreted by the latter than by the former.
3. All the cases relieved by this treatment gave positive skin reactions to their own proteoses before treatment, while, after treatment and cure, all those tested gave negative skin reactions.
